Abstract
LATE BREAKING CLINICAL TRIAL. Completion Date: February 2009. Sponsor: Ventracor, Inc. Summary of Objectives: The VentrAssist™ implantable left ventricular assist device (LVAD) is a third generation centrifugal pump with no mechanical bearings (it uses a hydronamically suspended impeller) designed to enhance reliability and decrease adverse events. This trial evaluates the efficacy and safety of the VentrAssist LVAD in BTT patients. The results of this trial will constitute the first report of a major trial of a centrifugal LVAD in the U.S.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
